TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Sarcoidosis in pregnancy

Key Statistics

  • 1:2000–1:10,464 — Prevalence in pregnancy
  • OR 1.62 — Pre-eclampsia risk (Hadid)
  • OR 6.68 — Pulmonary embolus risk (Hadid)

Don't-miss facts

  1. Sarcoidosis in pregnancy: multisystem, non-caseating granulomas; pulmonary artery hypertension and severe ILD (FVC <1–1.5 L) are high maternal mortality risks – MDT pre-pregnancy discussion essential

  2. Cardiac sarcoidosis (up to 39%): syncope may be first sign; arrhythmia risk 2–7%; ICDs safe in pregnancy but need interrogation ± deactivation in labour

  3. Postnatal flare is common – 25/38 new diagnoses in the Selroos cohort occurred within 1 year of delivery; plan postnatal flare suppression

  4. Serum ACE is unreliable for monitoring in pregnancy

  5. Aspirin from 12 weeks; avoid calcium/vitamin D supplementation (abnormal calcium metabolism)

  6. Methotrexate and MMF contraindicated in pregnancy/breastfeeding; methotrexate stop 4 weeks pre-conception (+folate 5 mg/day to 12 weeks if late stop); MMF stop ≥6 weeks pre-conception

  7. Sarcoidosis alone is not an indication for caesarean section, but consider cardiorespiratory reserve and shortened second stage

  8. Hadid registry: ↑PE (OR 6.68), ↑DVT (OR 4.92), ↑pre-eclampsia (OR 1.62); Köcher registry: ↑emergency CS, ↑pre- eclampsia (RR 1.6), no ↑VTE

Drug safety at a glance

Safe: corticosteroids, azathioprine, anti-TNF biologics (with timing caveats) Avoid: methotrexate, MMF, leflunomide

Abbreviation Key

  • TH1/TH2 — T helper 1 / T helper 2 lymphocyte response
  • EMG — electromyography
  • Treg — regulatory T cell
  • ICD — implantable cardiac defibrillator
  • TNF-α — tumour necrosis factor alpha
  • MMF — mycophenolate mofetil
  • ILD — interstitial lung disease
  • Anti-TNF — anti-tumour necrosis factor biologic therapy
  • FVC — forced vital capacity
  • IUD — intra-uterine death
  • ACE — angiotensin converting enzyme
  • PPH — postpartum haemorrhage
  • CT — computerised tomography
  • VTE — venous thromboembolism
  • MRI — magnetic resonance imaging
  • OR/RR — odds ratio / relative risk

Source: Odendaal J et al. Sarcoidosis in pregnancy. The Obstetrician & Gynaecologist 2024;26:66–74. doi:10.1111/tog.12917

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free